0000000000875595

AUTHOR

E Pennese

showing 2 related works from this author

Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study

2009

Lymphoid neoplasms bendamustinSettore MED/15 - Malattie Del Sangue
researchProduct

BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA

2010

At present, a prospectively validated treatment for SMZL is lacking. Despite this fact, splenectomy is still deemed to be the best choice for patients requiring treatment. Nevertheless, the high fraction of patients achieving a clinical response following splenectomy eventually relapses or progresses

splenic marginal zone lymphomabendamustineSettore MED/15 - Malattie Del Sangue
researchProduct